Eliem Therapeutics

Eliem cuts in on Tango, proposing acquisition after strategic review
Fierce Biotech
Tue, 03/19/24 - 11:51 am
Eliem Therapeutics
Tango Therapeutics
M&A
oncology
BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff
BioSpace
Thu, 02/16/23 - 11:18 am
layoffs
Grifols
Frequency Therapeutics
Eliem Therapeutics
Aligos Therapeutics
Thermo Fisher Scientific
Magenta Therapeutics
Eisai
Amgen
Y-mAbs Therapeutics
Century Therapeutics
Elevation Oncology
Calithera Biosciences
Editas Medicine
Verily
Abzena
Eliem drops depression drug, ending pursuit of Biogen-Sage and laying off 55% of team
Fierce Biotech
Fri, 02/10/23 - 10:25 am
Eliem Therapeutics
depression
layoffs
ETX-155
Drug makers leave the pain behind
EP Vantage
Fri, 08/26/22 - 10:26 am
painkillers
Acadia
Eli Lilly
Ampio Pharmaceuticals
Aptinyx
Eliem Therapeutics
Vertanical
Teva Pharamceutical
Regeneron
Vivozon
Vertex Pharmaceuticals
Biogen
Sometimes, Clinical Trials Miss the Mark: Neurocrine, Akebia, Eliem and Athira
BioSpace
Fri, 08/5/22 - 10:57 am
clinical trials
Neurocrine Biosciences
Akebia Therapeutics
Eliem Therapeutics
Athira Pharma
IPOs continue to bustle as three more biotechs prepare to make the Nasdaq leap
Endpoints
Mon, 07/19/21 - 11:13 pm
IPOs
Adagio Therapeutics
Castle Creek Biosciences
Eliem Therapeutics
Eliem raises $60M to take neuro programs to series of data drops
Fierce Biotech
Mon, 05/24/21 - 11:04 am
Eliem Therapeutics
funding
neuronal excitability disorders
neurology
Eliem exits stealth with $80M to run midphase pain trials, advance pipeline of neuro programs
Fierce Biotech
Thu, 03/25/21 - 11:53 am
Eliem Therapeutics
chronic pain
clinical trials
PEA